Hereditary breast cancer; Genetic penetrance and current status with BRCA
- PMID: 30552672
- DOI: 10.1002/jcp.27464
Hereditary breast cancer; Genetic penetrance and current status with BRCA
Abstract
The most important cause of developing hereditary breast cancer is germline mutations occurring in breast cancer (BCs) susceptibility genes, for example, BRCA1, BRCA2, TP53, CHEK2, PTEN, ATM, and PPM1D. Many BC susceptibility genes can be grouped into two classes, high- and low-penetrance genes, each of which interact with multiple genes and environmental factors. However, the penetrance of genes can also be represented by a spectrum, which ranges between high and low. Two of the most common susceptibility genes are BRCA1 and BRCA2, which perform vital cellular functions for repair of homologous DNA. Loss of heterozygosity accompanied by hereditary mutations in BRCA1 or BRCA2 increases chromosomal instability and the likelihood of cancer, as well as playing a key role in stimulating malignant transformation. With regard to pathological features, familial breast cancers caused by BRCA1 mutations usually differ from those caused by BRCA2 mutations and nonfamilial BCs. It is essential to acquire an understanding of these pathological features along with the genetic history of the patient to offer an individualized treatment. Germline mutations in BRCA1 and BRCA2 genes are the main genetic and inherited factors for breast and ovarian cancer. In fact, these mutations are very important in developing early onset and increasing the risk of familial breast and ovarian cancer and responsible for 90% of hereditary BC cases. Therefore, according to the conducted studies, screening of BRCA1 and BRCA2 genes is recommended as an important marker for early detection of all patients with breast or ovarian cancer risk with family history of the disease. In this review, we summarize the role of hereditary genes, mainly BRCA1 and BRCA2, in BC.
Keywords: BRCA; breast cancer; germline mutations; hereditary genes.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.Oncotarget. 2016 Dec 6;7(49):80465-80481. doi: 10.18632/oncotarget.12610. Oncotarget. 2016. PMID: 27741520 Free PMC article.
-
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4. Ann Surg Oncol. 2016. PMID: 26727920
-
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.Breast Cancer Res Treat. 2018 Apr;168(3):695-702. doi: 10.1007/s10549-017-4635-4. Epub 2018 Jan 2. Breast Cancer Res Treat. 2018. PMID: 29297111
-
Genetic Tests for Breast and Ovarian Cancer [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Feb. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 05-2008. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Feb. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 05-2008. PMID: 29319983 Free Books & Documents. Review.
-
Pathology of hereditary breast cancer.Cell Oncol (Dordr). 2011 Apr;34(2):71-88. doi: 10.1007/s13402-011-0010-3. Epub 2011 Feb 19. Cell Oncol (Dordr). 2011. PMID: 21336636 Free PMC article. Review.
Cited by
-
Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.Ann Surg Oncol. 2024 Oct;31(11):7290-7300. doi: 10.1245/s10434-024-15793-w. Epub 2024 Jul 8. Ann Surg Oncol. 2024. PMID: 38976158
-
Neutrophils and micronuclei: An emerging link between genomic instability and cancer-driven inflammation.Mutat Res. 2022 Jan-Jun;824:111778. doi: 10.1016/j.mrfmmm.2022.111778. Epub 2022 Mar 18. Mutat Res. 2022. PMID: 35334355 Free PMC article.
-
Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis.JMIR Form Res. 2023 Jan 19;7:e38399. doi: 10.2196/38399. JMIR Form Res. 2023. PMID: 36656633 Free PMC article.
-
Identification of metabolism-associated molecular subtype in ovarian cancer.J Cell Mol Med. 2021 Oct;25(20):9617-9626. doi: 10.1111/jcmm.16907. Epub 2021 Sep 15. J Cell Mol Med. 2021. PMID: 34523782 Free PMC article.
-
Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy.Obstet Gynecol Sci. 2024 Jul;67(4):343-355. doi: 10.5468/ogs.24054. Epub 2024 May 31. Obstet Gynecol Sci. 2024. PMID: 38817104 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous